The Beachbody Company (BODY) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
11 Nov, 2026Executive summary
Q3 revenue was $45.2M, down 24.5% YoY; net income was $3.3M and Adjusted EBITDA was $6.4M, both above guidance.
Fifth consecutive quarter of GAAP operating income and net income, and 12th consecutive quarter of positive Adjusted EBITDA.
Growth remained pressured by legacy subscriber attrition and slower retail rollout as strategy shifts toward nutrition and omni-channel distribution.
9M revenue declined 24.0% to $149.1M, while net income improved to $7.0M from an $8.1M loss and Adjusted EBITDA rose to $21.0M from $17.9M.
Financial highlights
Q3 gross profit was $32.0M and gross margin was 70.7%, down 390 bps YoY; operating expenses fell to $30.7M from $39.7M.
Q3 operating income was $1.3M versus $5.0M; adjusted net income was $0.6M versus $4.3M, and Adjusted EBITDA was $6.4M versus $9.5M.
9M operating expenses decreased 31% to $100.6M; adjusted net income was $4.0M versus an adjusted net loss of $3.6M.
Q3 net income included a $2.7M noncash gain from warrant fair-value changes.
Outlook and guidance
Q4 revenue guidance is $38M–$42M; net income is forecast at -$2M to $1M, adjusted net income at $1M–$4M, and Adjusted EBITDA at $6M–$9M.
Q4 outlook includes ~$3M of restructuring expense, primarily termination benefits; the October nutrition restructuring is expected to reduce headcount by ~80 employees, or 31% of the workforce.
Management expects adequate liquidity for operations and debt service for at least 12 months and plans continued cost control and working-capital management.
Latest events from The Beachbody Company
- Turnaround success enables accelerated innovation and retail expansion, boosting growth prospects.BODY
Canaccord Genuity's 46th Annual Growth Conference - Turnaround success drives profitability and innovation, with major retail launches in 2026.BODY
Investor presentation - Fourth consecutive quarter of profitability despite a 22% revenue decline.BODY
Q2 2026 - Turnaround success, new retail launches, and digital innovation set the stage for 2026 growth.BODY
Sidoti's Year End Virtual Investor Conference - Turnaround completed ahead of schedule, with new products and retail expansion driving future growth.BODY
Sidoti Small-Cap Virtual Investor Conference - Turnaround success and retail expansion set the stage for accelerated growth in 2027.BODY
Noble Capital Markets June 2026 Emerging Growth Virtual Equity Conference - Turnaround success: multi-channel strategy, retail launches, and 10 straight profitable quarters.BODY
16th Annual LD Micro Invitational Conference - First net income since IPO, improved margins, and ongoing liquidity risks.BODY
Q3 2025 - Gross margin rose to 67% as affiliate model pivot and restructuring narrowed net loss.BODY
Q3 2024